Pubblicazioni

First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison

2018 - HIV MEDICINE
Taramasso, L.; Di Biagio, A.; Maggiolo, F.; Tavelli, A.; Lo Caputo, S.; Bonora, S.; Zaccarelli, M.; Caramello, P.; Costantini, A.; Viscoli, C.; d’Arminio Monforte, A.; Cozzi-Lepri, A.; Italian Cohort Naive Antiretrovirals (ICONA) Foundation Study Group, The; Lichtner, M.; Mastroianni, C. M.; Belvisi, V.; Vullo, V.; Savinelli, S.

Pharmacogenetics of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in resource-limited settings: influence on antiretroviral therapy response and concomitant anti-tubercular, antimalarial and contraceptive treatments

2016 - INFECTION GENETICS AND EVOLUTION
Russo, Gianluca; Paganotti, Giacomo Maria; Soeria-Atmadja, Sandra; Haverkamp, Miriam; Ramogola-Masire, Doreen; Vullo, Vincenzo; Gustafsson, Lars Lennart

CYP2B6 poor metaboliser alleles involved in efavirenz and nevirapine metabolism. CYP2B6*9 and CYP2B6*18 distribution in HIV-exposed subjects from Dschang, Western Cameroon

2015 - INFECTION GENETICS AND EVOLUTION
Russo, Gianluca; Sobze, Martin Sanou; Mayaka, George Bouting; Muthoga, Charles Waithaka; Tawe, Leabaneng; Martinelli, Axel; Romano, Rita; Vullo, Vincenzo; Paganotti, Giacomo Maria

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma